| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2019) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | N04CX01 |
| UNII: | 2GZ0LIK7T4 |
| InChI Key | IQVRBWUUXZMOPW-PKNBQFBNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H24N4O4 |
| Molecular Weight | 384.44 |
| AlogP | 2.12 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 80.28 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Adenosine A2a receptor antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 13000 | - | - | - | |
|
Enzyme
Oxidoreductase
|
- | - | - | 27 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Nucleotide-like receptor (family A GPCR)
Adenosine receptor
|
- | 5248-5250 | 1259 | 2-200 | 47 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 155270-99-8 |
| ChEBI | 134726 |
| ChEMBL | CHEMBL431770 |
| DrugBank | DB11757 |
| DrugCentral | 4882 |
| EPA CompTox | DTXSID7057652 |
| FDA SRS | 2GZ0LIK7T4 |
| Guide to Pharmacology | 5608 |
| PubChem | 5311037 |
| SureChEMBL | SCHEMBL633262 |
| ZINC | ZINC000003803921 |